Literature DB >> 20362236

Heroin-assisted treatment in the Netherlands: History, findings, and international context.

Peter Blanken1, Wim van den Brink, Vincent M Hendriks, Ineke A Huijsman, Marjolein G Klous, Elisabeth J Rook, Jennifer S Wakelin, Cas Barendrecht, Jos H Beijnen, Jan M van Ree.   

Abstract

This monograph describes the history, findings and international context of heroin-assisted treatment (HAT) in the Netherlands. The monograph consists of (1) a short introduction and seven paragraphs describing the following aspects of HAT in the Netherlands: (2) history of HAT studies and implementation of routine HAT in the Netherlands; (3) main findings on efficacy, safety and cost-effectiveness from the two randomized controlled HAT trials in the Netherlands; (4) new findings from a large cohort study on the effectiveness of HAT in routine clinical practice in the Netherlands; (5) unique data on the patient's perspective of HAT; (6) data on the pharmacological and pharmaceutical basis for HAT in the Netherlands; (7) description of the registration process; and (8) account of the international context of HAT. Together, these data show that HAT can now be considered a safe and proven-effective intervention for the treatment of chronic, treatment-resistant heroin dependent patients. Copyright 2010 Elsevier B.V. and ECNP. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362236     DOI: 10.1016/S0924-977X(10)70001-8

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  14 in total

1.  Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use.

Authors:  Vadim Yuferov; Matthew Randesi; Eduardo R Butelman; Wim van den Brink; Peter Blanken; Jan M van Ree; Jürg Ott; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2019-03-29       Impact factor: 3.046

2.  Un Jalón, Un Volteón, y Otra Vez: High-Risk Crack Smoking Paraphernalia in México City.

Authors:  Avelardo Valdez; Kathryn M Nowotny; Nalini Negi; Eduardo Zafra Mora; Alice Cepeda
Journal:  J Psychoactive Drugs       Date:  2016-06-29

Review 3.  Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.

Authors:  James Bell; Vendula Belackova; Nicholas Lintzeris
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  Treating Addictions: Harm Reduction in Clinical Care and Prevention.

Authors:  Ernest Drucker; Kenneth Anderson; Robert Haemmig; Robert Heimer; Dan Small; Alex Walley; Evan Wood; Ingrid van Beek
Journal:  J Bioeth Inq       Date:  2016-04-26       Impact factor: 1.352

5.  VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2019-04-15       Impact factor: 2.533

6.  Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Vadim Yuferov; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2017-12-06       Impact factor: 2.533

7.  Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Eduardo R Butelman; Vadim Yuferov; Joel Correa da Rosa; Jurg Ott; Jan M van Ree; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2016-09-05       Impact factor: 4.492

8.  HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

Authors:  Don C Des Jarlais; Dennis McCarty; William A Vega; Heidi Bramson
Journal:  Am Psychol       Date:  2013 May-Jun

9.  Yet they failed to do so: recommendations based on the experiences of NAOMI research survivors and a call for action.

Authors:  Susan Boyd
Journal:  Harm Reduct J       Date:  2013-04-18

10.  The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Scott MacDonald; Daphne Guh; Martin T Schechter
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.